Global Human Insulin Market to Reach US$ 84.2 Billion by 2032, Propelled by Surging Incidences of Diabetes

August 18, 2020 | Healthcare

IMARC Group’s latest report, titled “Human Insulin Market Report by Product Type (Drugs, Delivery Devices), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Retail Stores, and Others), Disease Type (Type I Diabetes, Type II Diabetes), and Region 2024-2032,” finds that the global human insulin market size reached US$ 48.2 Billion in 2023. Human insulin (HI), also known as regular insulin, refers to short-acting insulin synthesized in laboratories. It mimics the function of insulin naturally produced by the human body and is generally injected subcutaneously multiple times a day. It is bio-engineered by growing insulin proteins within E-coli bacteria (Escherichia coli) cells.It is widely used to regulate blood sugar levels in patients with type I and II diabetes and promote glucose uptake from the blood into internal organs and tissues, such as liver and fat cells. It also inhibits hepatic glucose production and enhances the protein synthesis of the body.

Global Human Insulin Market Trends:

The surging incidences of diabetes due to the aging population, sedentary lifestyles, and unhealthy dietary habits represent the primary factor driving the market growth. Additionally, there has been growing consumer awareness regarding the complications of prolonged diabetes, such as cataracts, heart attacks, and kidney failure. In line with this, the escalating demand for biosimilar drugs on account of their high efficiency and cost-effectiveness has catalyzed market growth. Furthermore, several key players are extensively investing in research and development (R&D) activities to develop oral insulin variants that provide a safe, effective, and convenient method of delivering insulin therapy. Apart from this, the introduction of pen devices and safety pen needles that cause minimal discomfort and reduce the risks of injuries, infections, and bloodborne pathogen transmission has accelerated the product adoption rate. Moreover, the implementation of stringent government policies against needle stick injuries and the shifting consumer preferences toward minimally invasive (MI) devices have encouraged the usage of pen devices and safety pen needles for HI administration. Other factors, including the expanding obese population, improving healthcare infrastructure, increasing consumer health consciousness, recent advancements in the biotechnology field, and product innovations, are also providing a positive thrust to the market growth. Looking forward, the market value is expected to reach US$ 84.2 Billion by 2032, exhibiting a CAGR of 6.2% during the forecast period (2024-2032).

Market Summary:

  • Based on the product type, the market has been bifurcated into drugs [human insulin analogs and biosimilars (rapid acting, long acting and premixed) and human insulin biologics (short acting, intermediate acting and premixed)] and delivery devices [pens (reusable and disposable pens), pen needles (standard and safety pen needles), syringes, and others)].
  • On the basis of the distribution channel, the market has been categorized into retail pharmacies, hospital pharmacies, online retail stores, and others.
  • The market has been divided based on the disease type into type I and II diabetes. 
  • Region-wise, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Biocon Limited, Eli Lilly and Company, Gulf Pharmaceutical Industries (Julphar), Novo Nordisk A/S, Pfizer Inc., Groupe Sanofi, SEDICO Co., Wockhardt Limited, and Ypsomed AG.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Human Insulin Market to Reach US$ 84.2 Billion by 2032, Propelled by Surging Incidences of Diabetes
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More